CN117501123A - Xx型胶原蛋白测定 - Google Patents

Xx型胶原蛋白测定 Download PDF

Info

Publication number
CN117501123A
CN117501123A CN202280040671.3A CN202280040671A CN117501123A CN 117501123 A CN117501123 A CN 117501123A CN 202280040671 A CN202280040671 A CN 202280040671A CN 117501123 A CN117501123 A CN 117501123A
Authority
CN
China
Prior art keywords
cancer
seq
monoclonal antibody
amino acid
ser
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202280040671.3A
Other languages
English (en)
Chinese (zh)
Inventor
J·索尔拉休斯-尤星
N·威勒姆森
M·A·卡斯达尔
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nordic Bioscience AS
Original Assignee
Nordic Bioscience AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nordic Bioscience AS filed Critical Nordic Bioscience AS
Publication of CN117501123A publication Critical patent/CN117501123A/zh
Pending legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/577—Immunoassay; Biospecific binding assay; Materials therefor involving monoclonal antibodies binding reaction mechanisms characterised by the use of monoclonal antibodies
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/70—Mechanisms involved in disease identification
    • G01N2800/7023—(Hyper)proliferation
    • G01N2800/7028—Cancer

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
CN202280040671.3A 2021-06-18 2022-06-17 Xx型胶原蛋白测定 Pending CN117501123A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB2108802.6 2021-06-18
GBGB2108802.6A GB202108802D0 (en) 2021-06-18 2021-06-18 Collagen type XX assay
PCT/EP2022/066635 WO2022263675A1 (en) 2021-06-18 2022-06-17 Collagen type xx assay

Publications (1)

Publication Number Publication Date
CN117501123A true CN117501123A (zh) 2024-02-02

Family

ID=77050621

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202280040671.3A Pending CN117501123A (zh) 2021-06-18 2022-06-17 Xx型胶原蛋白测定

Country Status (7)

Country Link
US (1) US20240385191A1 (https=)
EP (1) EP4356137B1 (https=)
JP (1) JP2024525130A (https=)
KR (1) KR20240022470A (https=)
CN (1) CN117501123A (https=)
GB (1) GB202108802D0 (https=)
WO (1) WO2022263675A1 (https=)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011051278A1 (en) * 2009-10-26 2011-05-05 Externautics S.P.A. Lung tumor markers and methods of use thereof
CN108546760A (zh) * 2018-04-24 2018-09-18 郑州大学第附属医院 一种胰腺癌预后分子标志物非编码RNA Lnc-COL20A1-2及其应用

Also Published As

Publication number Publication date
JP2024525130A (ja) 2024-07-10
US20240385191A1 (en) 2024-11-21
GB202108802D0 (en) 2021-08-04
WO2022263675A1 (en) 2022-12-22
EP4356137C0 (en) 2025-07-23
EP4356137B1 (en) 2025-07-23
KR20240022470A (ko) 2024-02-20
EP4356137A1 (en) 2024-04-24

Similar Documents

Publication Publication Date Title
KR20180102647A (ko) 콜라겐 타입 vii 알파 1 분석
CN117083293A (zh) 用于检测胶原xi生物标志物的测定
EP4356137B1 (en) Collagen type xx assay
CN114746755B (zh) 测量蛋白酶介导的iv型胶原蛋白降解的新表位特异性测定
US20230358752A1 (en) Assay for Assessing Cancer
US20250085286A1 (en) Collagen Type XXII Assay
US20260126445A1 (en) Assay for Assessing Cancer
JP7704771B2 (ja) Ｘｉｘ型コラーゲンのアッセイ
US20260029403A1 (en) Type XIX Collagen Assay
JP2025533448A (ja) 軟骨中間層蛋白－１のタンパク質分解的切断生成物のｎ－末端ペプチドを検出するためのイムノアッセイ
EP4627346A1 (en) Assay for detecting cancer by using an antibody that binds to c-terminal epitope of type ix collagen
AU2024239548A1 (en) C3f assay
CN117083294A (zh) 用于检测胶原xviii生物标志物的测定
CN111656192A (zh) 肿瘤抑素测定

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination